MY3-18385-77016
3 vaccinations
4 coded responses
31 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 919 / CA
- Registered
- 2022-09-15
- Relationship
- Child or adolescent in my care
- Guardian
- PN6-33091-18427
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-15
Registered in v-safe
-
2022-09-15
Dose 1 — Pfizer-BioNTech
-
2022-09-15
Health check-in — day 0, dose 1, under 3Feeling: Poor · Site: Pain, Redness · Irritability/crying, Loss of appetite · Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-09-16
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-21
- 2022-09-23
-
2022-09-29
Survey response — day 14, dose 1, under 3MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose, sneezing, cough, congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-07
-
2022-10-13
Dose 2 — Pfizer-BioNTech
-
2022-10-13
Health check-in — day 0, dose 2, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-10-14
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: Poor · Fever · Irritability/cryingFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Poor · Site: Swelling/hardness · Fever · Sleepiness, Irritability/crying, Loss of appetite · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationUnder 3 check-in
-
2022-10-16
Report sent to call center — days 1–6 daily, dose 2, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-17
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Swelling/hardness · Fever · Sleepiness, Irritability/cryingUnder 3 check-in
- 2022-10-17
- 2022-10-21
- 2022-10-29
-
2022-11-03
Survey response — day 21, dose 2, under 3MedDRA: Cough, Nasal congestion — Feeling: FairFree text: Cough, stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-10
Survey response — day 28, dose 2, under 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Runny, stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2022-11-25
-
2022-12-09
Dose 3 — Pfizer-BioNTech
- 2022-12-10
-
2022-12-11
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Fair · Site: Swelling/hardness · NoneUnder 3 check-in
- 2022-12-12
- 2022-12-14
- 2022-12-15
- 2022-12-16
- 2022-12-23
- 2022-12-30
- 2023-01-08
- 2023-01-13
- 2023-01-21
- 2023-03-10
- 2023-06-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-15 | Pfizer-BioNTech | No |
| 2 | 2022-10-13 | Pfizer-BioNTech | No |
| 3 | 2022-12-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Runny nose, sneezing, cough, congestion
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Runny nose
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Cough, stuffy nose
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Runny, stuffy nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release